TrialClinical drug investigation2008
Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection.
Pedro Cahn et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it